Skip to content

Development of an Exoskeleton for Patients' Mobility.

The Development of an Exoskeleton System for Assisting and Enhancing Patients' Mobility.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06513390
Enrollment
8
Registered
2024-07-22
Start date
2022-07-01
Completion date
2022-07-12
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Exoskeleton, Gait, Kinematics, Temporal spatial, Muscle activity, Oxygen consumption

Brief summary

The goal of this clinical trial is to investigate the performance of a state-of-the-art adaptive CPG-based exoskeleton control system (intelligent mode) under a multi-metric analysis (involving three-dimensional gait analysis, muscle activity, oxygen consumption, user comfort, and exoskeleton performance scores) and comparing it to a standard commercial exoskeleton control system (default mode) The main question it aims to answer is: Could the adaptive version improve natural walking and essential lower limb motions? Participants will: All participants were assigned into two groups to receive an alternate sequence of walking with the intelligent mode or the default mode of the lower-limb exoskeleton Exo-H3 at high and normal speed.

Interventions

DEVICEExoskeleton of default mode

Default mode: A standard control system offering a conventional assistive function of Exo-H3.

DEVICEExoskeleton of Intelligent mode

Intelligent mode: The adaptive CPG-based control system developed by our researchers from Exo-H3.

Sponsors

Vidyasirimedhi Institute of Science & Technology (VISTEC)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy Thai adults * age between 18 and 60 years old * body mass index between 18.5 and 24.9 kg/m2 * walk independently * willing to participate in the study

Exclusion criteria

* a history of surgery in the back, hip, knee, or ankle area * previous injury or pain in the hip, knee, or ankle area that would affect walking patterns within the past 6 months * a history of musculoskeletal or neuromuscular disease such as multiple sclerosis, myasthenia gravis * a balance disorder * unable to continue or withdrawal from the study

Design outcomes

Primary

MeasureTime frameDescription
gait kinematic of pelvic hip, knee and ankle joint.1 dayThe average of pelvic-hip-knee-ankle angles (degrees) in frontal, sagittal and transverse plance were collected by using three dimensions with an eight-camera Motion analysis (Motion Analysis Corporation, Santa Rosa, CA, USA).

Secondary

MeasureTime frameDescription
Temporal spatial data of cadence1 dayMean cadence (step/min) was collected by an eight-camera Motion analysis (Motion Analysis Corporation, Santa Rosa, CA, USA).
Temporal spatial data of step length, step width, and stride length1 dayMean of step length(cm), step width(cm), and stride length(cm) were collected by an eight-camera Motion analysis (Motion Analysis Corporation, Santa Rosa, CA, USA).
Temporal spatial data of stance phase and swing phase time1 dayMean percentage of stance phase and swing phase time were collected by an eight-camera Motion analysis (Motion Analysis Corporation, Santa Rosa, CA, USA).
Temporal spatial data of velocity1 dayMean velocity (m/s) was collected by an eight-camera Motion analysis (Motion Analysis Corporation, Santa Rosa, CA, USA).
Oxygen consumption1 dayVO2 MAX (ml/kg/min) was estimated for the walking trial.
user comfort scores1 dayThe wearer's opinion to the device, their perceived change, emotion on self-image, anxiety on security, harm or painful, attachment, and movement were evaluated as the comfort score. Each item rated from a 1 (the least problem) to 5 (the most problem). Sum of total score was 30, and categorized as very comfortable (1-6 points), comfortable (7-17 points), moderately comfortable (18 points), uncomfortable (19-29 points), and uncomfortable at all (30 points). The outcome was measured after completing the walk in each exoskeleton mode.
exoskeleton performance scores1 dayThe exoskeletal performance questionnaire comprised 2 domains; pain (walking, climbing stairs, rising from sitting, standing) and difficulty (descending stairs, ascending stairs, rising from sitting, standing, bending to floor, walking on even floor, walking for distance). Each item rated from 1 (minimal issues) to 5 (significant problems). The total performance score was designated as the best performance (1-11 points), good performance (12-13 points), moderate performance (33 point), poor performance (34-54 points), and the worst performance (55 points).
Muscle activity1 dayBilateral muscles activities of gluteus medius, gluteus maximus, tensor fascia latae, rectus femoris, bicep femoris, medial gastrocnemius, and tibialis anterior muscles during walking were quantified as root mean square (RMS) in the voltage

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026